Devonian Health Group Inc. announces its participation to the ThinkEquity Conference in New York and closing of a Non-Brokered Private Placement of Units
PRESS RELEASE For immediate release Devonian Health Group Inc. announces its participation to the ThinkEquity Conference in New York and closing of a Non-Brokered Private Placement of Units NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION...
Devonian Provides Corporate Update and Additional Information Regarding its Previously Announced Private Placement
PRESS RELEASE For immediate release Devonian Provides Corporate Update and Additional Information Regarding its Previously Announced Private Placement QUEBEC, August 22, 2025 – Devonian Health Group Inc. (“Devonian” or the “Corporation”) (TSXV: GSD; OTCQB: DVHGF), a...
Devonian Announces Closing of a Private Placement of Units
PRESS RELEASE For immediate release Devonian Announces Closing of a Private Placement of Units Not for distribution to United States newswire services or for dissemination in the United States QUEBEC, August 7, 2025 – Devonian Health Group Inc. (“Devonian” or the...
Devonian Health Group Reports Third Quarter 2025 Financial Results
PRESS RELEASE For immediate release Devonian Health Group Reports Third Quarter 2025 Financial Results Third quarter revenues increased 36% compared to 3Q24 Third quarter net loss of $0.032 per share Québec, QUÉBEC, June 26, 2025 – Devonian Health Group Inc....
DEVONIAN APPOINTS NEW OFFICERS AND ANNOUNCES GRANT OF STOCK OPTIONS
PRESS RELEASE For immediate release DEVONIAN APPOINTS NEW OFFICERS AND ANNOUNCES GRANT OF STOCK OPTIONS QUÉBEC, Québec, June 9, 2025 – Devonian Health Group Inc. (“Devonian” or the “Corporation”) (TSXV: GSD; OTCQB: DVHGF), a clinical stage corporation focused on...
Devonian Health Group Announces Reinstatement of Quotation on the TSXV
PRESS RELEASE For immediate release Devonian Health Group Announces Reinstatement of Quotation on the TSXV QUÉBEC, April 28, 2025 – Devonian Health Group Inc. (“Devonian” or the “Company”) (TSXV: GSD; OTCQB: DVHGF), announced that the TSX Venture Exchange...
Devonian Health Group Reports Second Quarter 2025 Financial Results
PRESS RELEASE For immediate release Devonian Health Group Reports Second Quarter 2025 Financial Results Second quarter revenue increased 275% year over year Second quarter net loss of $0.001 per share Debt repaid in full Québec, QUÉBEC, April 15, 2025 – Devonian...
Devonian Health Group Reports Cease Trade Order
PRESS RELEASE For immediate release Devonian Health Group Reports Cease Trade Order QUEBEC CITY--(BUSINESS WIRE)--April 14, 2025--Devonian Health Group Inc. (“Devonian” or the “Company”) (TSXV: GSD; OTCQB: DVHGF), announces that the Autorité des Marchés Financiers...
Devonian Reports Delay of Financial Reporting
PRESS RELEASE For immediate release Devonian Reports Delay of Financial Reporting QUÉBEC, April 1st, 2025 – Devonian Health Group Inc. (“Devonian” or the “Corporation”) (TSXV: GSD; OTCQB: DVHGF), a clinical stage corporation focused on developing unique solutions to...
Devonian Reports Results of its Annual General and Special Meeting of Shareholders
PRESS RELEASE For immediate release Devonian Reports Results of its Annual General and Special Meeting of Shareholders Not for distribution to United States newswire services or for dissemination in the United States QUEBEC, March 24, 2025 – Devonian Health Group Inc....